Twin Tree Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,641
Closed -$1.24M 1267
2025
Q4
$1.45M Sell
3,641
-12,364
-77% -$5.47M 0.15% 915
2025
Q3
$7.3M Buy
+16,005
New +$6.52M 0.34% 621
2025
Q2
Sell
-7,074
Closed -$1.96M 1585
2025
Q1
$1.91M Buy
+7,074
New +$1.82M 0.04% 1152
2024
Q4
Hold
0
1569
2024
Q3
Sell
-43,749
Closed -$11.4M 1501
2024
Q2
$10.6M Buy
43,749
+28,239
+182% +$4.46M 0.31% 564
2024
Q1
$2.32M Buy
+15,510
New +$2.59M 0.05% 969
2023
Q4
Sell
-6,289
Closed -$1.07M 1365
2023
Q3
$1.11M Buy
+6,289
New +$1.2M 0.04% 960
2023
Q1
Hold
0
1271
2022
Q4
Sell
-72,861
Closed -$15.5M 1270
2022
Q3
$14.6M Buy
72,861
+63,421
+672% +$12.1M 0.4% 452
2022
Q2
$1.38M Sell
9,440
-22,344
-70% -$3.17M 0.03% 1155
2022
Q1
$5.19M Buy
+31,784
New +$4.84M 0.1% 915
2021
Q4
Hold
0
1575
2021
Q3
Sell
-16,500
Closed -$3.1M 1549
2021
Q2
$2.8M Buy
+16,500
New +$2.42M 0.08% 818
2020
Q4
Sell
-134
Closed -$20K 1263
2020
Q3
$20K Buy
134
+117
+688% +$16.6K ﹤0.01% 1141
2020
Q2
$3K Buy
+17
New +$2.29K ﹤0.01% 1416
2020
Q1
Hold
0
1338
2019
Q4
Hold
0
1226
2019
Q2
Hold
0
1223
2019
Q1
Sell
-5,919
Closed -$495K 1296
2018
Q4
$432K Sell
5,919
-18,788
-76% -$1.45M 0.03% 987
2018
Q3
$2.16M Buy
24,707
+16,180
+190% +$1.63M 0.2% 574
2018
Q2
$840K Buy
+8,527
New +$846K 0.05% 812
2018
Q1
Hold
0
1100
2017
Q4
Hold
0
997
2017
Q3
Hold
0
962

Other funds holding ALNY